Frontiers | Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders
Phosphatidylserine is a marker for axonal debris engulfment but its exposure can be decoupled from degeneration | Cell Death & Disease
Sarm1 knockout protects against early but not late axonal degeneration in experimental allergic encephalomyelitis | PLOS ONE
Caspase-mediated cleavage of actin and tubulin is a common feature and sensitive marker of axonal degeneration in neural development and injury | Acta Neuropathologica Communications | Full Text
Regulatory mechanisms for the axonal localization of tau in neurons | bioRxiv
The levels of Neurofilament and the axonal degeneration marker pMAPT in... | Download Scientific Diagram
The presence of synapse loss, a marker of axon degeneration at... | Download Scientific Diagram
Studying axonal degeneration and regeneration using in vitro and in vivo models: the translational potential | Future Neurology
Frontiers | Oxidative Stress-Induced Axon Fragmentation Is a Consequence of Reduced Axonal Transport in Hereditary Spastic Paraplegia SPAST Patient Neurons
Axonal degeneration in multiple sclerosis: defining therapeutic targets by identifying the causes of pathology | Neurodegenerative Disease Management
A Quantitative Model of Sporadic Axonal Degeneration in the Drosophila Visual System | Journal of Neuroscience
Axonal degeneration in an in vitro model of ischemic white matter injury - ScienceDirect
Wallerian Degeneration Is Executed by an NMN-SARM1-Dependent Late Ca2+ Influx but Only Modestly Influenced by Mitochondria - ScienceDirect
In vivo imaging of injured cortical axons reveals a rapid onset form of Wallerian degeneration | BMC Biology | Full Text
Myelin Loss Does Not Lead to Axonal Degeneration in a Long-Lived Model of Chronic Demyelination | Journal of Neuroscience
Axonal degeneration in an in vitro model of ischemic white matter injury - ScienceDirect
Axon death signalling in Wallerian degeneration among species and in disease | Open Biology
Frontiers | Axonal Degeneration in AD: The Contribution of Aβ and Tau
Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel | PLOS ONE
SCG10 is a JNK target in the axonal degeneration pathway | PNAS
Modeling axonal regeneration by changing cytoskeletal dynamics in stem cell-derived motor nerve organoids | Scientific Reports